Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2000Journal of Antimicrobial ChemotherapyOpen Access

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)

View Full Paper
Ask AI
Bookmark
Share

Authors

EMElias K. ManavathuAugusta University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elias K. Manavathu (2000) studied this question.

synapsesocial.com/papers/6a6f6da435aa2c282ce0ca77https://doi.org/10.1093/jac/46.2.229
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi1997 · 228 citations
  2. 2Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae1997 · 92 citations
  3. 3Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus1997 · 109 citations
  4. 4In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans1996 · 128 citations
  5. 5National Committee for Clinical Laboratory Standards1980 · 14,792 citations